Maxifed
Product Images NDC 58605-101

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Maxifed (NDC 58605-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mcr American Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (360 mg/60 mg Tablet Bottle Label)

Maxifed 360 mg/60 mg immediate-release tablets, an expectorant and nasal decongestant, manufactured by MCR American Pharmaceuticals, Inc. The label shows the active ingredients guaifenesin and pseudoephedrine HCl, package contains 100 tablets, with storage instructions and a barcode. The label includes warnings, directions, and inactive ingredients, consistent with typical drug packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.